坤彩科技(603826.SH)股東榕坤投資質押380萬股
格隆匯5月27日丨坤彩科技(603826.SH)公佈,公司於2020年5月27日接到股東榕坤投資函告,獲悉其所持有公司的部分股份被質押,此次質押380萬股,佔其所持股份比例23.82%。
截至目前,公司股東榕坤投資(福建)有限公司(“榕坤投資”)持有公司股份約1595.45萬股,佔公司總股本的3.41%,榕坤投資控股股東謝秉昆持有榕坤投資49.31%股份,謝秉昆通過榕坤投資間接持有公司股份7867186股,佔公司總股本的1.68%。榕坤投資持有上市公司股份累計質押數量380萬股,佔其持股數量比例23.82%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.